The Antibacterial Resistance Leadership Group (ARLG), the European Clinical Research Alliance on Infectious Diseases (Ecraid), and ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network have united to combat antibacterial resistance globally. This alliance leverages ARLG’s focus in the Americas, Ecraid’s influence in Europe, and ADVANCE-ID’s presence in the Asia Pacific. Through streamlined communication and shared resources, the groups aim to advance infectious disease clinical research. The collaboration entails cross-entity engagement, harmonized procedures, and joint initiatives for research, data sharing, and education. It establishes a consultative framework for geographical areas and ensures equitable leadership distribution. This partnership exemplifies global cooperation in addressing the antibacterial resistance public health crisis.

View the full release here.